Rep. Roy introduces RESULT acts amid the coronavirus pandemic
Rep. Roy introduces RESULT acts amid the coronavirus pandemic.
As COVID-19 continues to spread throughout the world, it is important the United States has the ability to work with other nations to ensure we have quick access to necessary medicines and medical devices. This is why I am introducing the RESULT for Coronavirus Patients Act, along with the RESULT act that also includes non-coronavirus medicines and devices.
Under these bills, the U.S. Food and Drug Administration (FDA) would have 30 days to review applications for drugs and medical devices that have been approved in comparable countries for sale and marketing in the U.S. This will cut through red tape and regulations at the FDA that prevent Americans from obtaining quick access to needed medical items. FDA approval costs and lack of efficiency in the FDA process stymie medical innovation and access for Americans.
A global pandemic like the coronavirus, deserves a global medical response, but this can also be true for our drug approval process when we are not under a global emergency. Doctors and scientist around the world have been rushing to develop new medicines, treatments, and devices to prevent the spread of COVID-19, and other diseases that threaten our lives. There is no reason the U.S. should be prevented from accessing these products within one month.